Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial.

MacKenzie Feder, Jessica; Bourdeau, Isabelle; Vallette, Sophie; Beauregard, Hugues; Ste-Marie, Louis-Georges; Lacroix, André.
Pituitary; 17(6): 519-29, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24287689